Glenmark Pharma - Nearing buy zone on weekly chart

The stock took support at the 40 weekly moving average and is hovering near the buy zone.

Positive momentum expected above the levels of 925 for an initial target of 1100.
Will review once the target is achieved.

Strict stop loss at 5-8%.

Note: Not a buy/sell recommendation. Consult your financial advisor.